Olema Oncology announced that it has strengthened its executive team with the appointment of Shane Kovacs as Chief Financial Officer. Kovacs will lead company's financial strategy, accounting, information technology and human resources functions. Shane Kovacs has more than 20 years of biotechnology operating experience, including a strong background in capital markets and M&A. Prior to joining, he was Chief Business and Financial Officer of BlueRock Therapeutics, LP.